TrialBritish journal of cancer2025

Overall survival with maintenance olaparib in platinum-sensitive relapsed ovarian cancer by somatic or germline BRCA and homologous recombination repair mutation status.

Sandro Pignata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.